FDA Gets $2.6 Billion to Finish Fiscal Year

March 19, 2009
Angie Drakulich
ePT--the Electronic Newsletter of Pharmaceutical Technology

President Barack Obama signed the fiscal year 2009 Ombnibus Appropriations Act on Mar. 11, 2009, giving the US Food and Drug Administration $2.6 billion. The funding can be used through the end of the fiscal year, Sept. 30, 2009.

President Barack Obama signed the fiscal year 2009 Omnibus Appropriations Act on Mar. 11, 2009, giving the US Food and Drug Administration $2.6 billion. The funding can be used through the fiscal year, which ends on Sept. 30, 2009.

Of the funds, $2 billion go directly to FDA. The Center for Drug Evaluation and Research will receive approximately $777 million for its activities and those of the Office of Regulatory Affairs (ORA), $41 million of which will go to the Office of Generic Drugs. The Center for Biologics Evaluation and Research will receive about $271 million for its activities and those of ORA. Approximately $511 million of the funding will come from prescription drug user fees.

In December 2007, Congress enacted the FY 2008 Omnibus Appropriations Act, which gave FDA $1.714 billion, and in June 2008, Congress gave the agency another $150 million as part of the FY 2008 emergency supplemental appropriations bill.